Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $286,922 - $401,033
1,257 New
1,257 $400,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $2.35 Million - $3.2 Million
11,407 Added 47529.17%
11,431 $3.18 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $4,879 - $5,860
24 New
24 $5,000
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $4,370 - $6,028
-25 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $3,655 - $4,707
22 Added 733.33%
25 $4,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $14,745 - $17,286
-80 Reduced 96.39%
3 $1,000
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $14,928 - $17,835
83 New
83 $15,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.